抗うつ薬による神経免疫サイトカインネットワークの調節:気分調節への影響
Roseane Galdioli Nava1,2, Anny Silva Adri3,4, Igor Salerno Filgueiras3,5
1Interunit Postgraduate Program on Bioinformatics, Institute of Chemistry of the University of São Paulo (IQ-USP), University of Sao Paulo (USP), Sao Paulo, SP, Brazil. roseanenava@usp.br.
Translational psychiatry
|August 23, 2025
まとめ
抗うつ剤は,神経伝達物質の作用を超えて,細胞キンのバランスを変化させることで,重度うつ病 (MDD) の免疫反応を調節する. この免疫調節は 鬱病の治療の新たな道を開きます 特に治療に抵抗するケースです
科学分野:
- 神経科学
- 免疫学
- 精神科
背景:
- 重度のうつ病 (MDD) は,神経炎症状態としてますます理解されています.
- サイトカインネットワークの調節障害はMDDの病原性において重要な役割を果たします.
研究 の 目的:
- 抗うつ薬の免疫調節効果を見直すため
- Th1/Th2 サイトカインバランスに対する抗うつ薬の影響を調べる
- 抗うつ薬の作用の主要なメカニズムとして免疫調節を確立する.
主な方法:
- 臨床研究と翻訳研究に関する包括的な文献レビュー
- 炎症誘発性および抗炎症性サイトカインに対する抗うつ薬の効果に関するデータの分析
- MDDに対する新興免疫調節介入の検討
主要な成果:
- 抗うつ薬は一貫して免疫調節性を持ち,炎症誘発性サイトカイン (IFN-γ,TNF-α,IL-6) を減らし,抗炎症性サイトカイン (IL-10,TGF-β) を増加させる.
- これらの効果は,発症時の炎症が高い治療抵抗性MDDにおいて有意である.
- IL-2免疫療法や 迷走神経刺激のような新興治療は 期待を裏切るものですが 特に炎症バイオマーカーに 導かれる治療は 期待を裏切るものなのです
結論:
- 免疫調節は抗うつ薬の働きの 根本的な側面です
- 神経免疫経路をターゲットにすることで 新しいMDD治療法の開発の枠組みが提供されます
- 炎症性バイオマーカーに 基づくパーソナライズされた治療戦略は 炎症に関連したうつ病に不可欠です
関連する概念動画
Antidepressant Drugs: Overview
750
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
750
Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
Neurotransmitters
1.5K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
1.5K
Depression: Overview
332
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
332
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
568
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
568
Depressive Disorders: Etiology
166
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
166


